We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRE icon
2001
Green Plains
GPRE
$1.05B
$128K ﹤0.01%
8,322
+1,163
+16% +$18.5K
TRN icon
2002
Trinity Industries
TRN
$2.22B
$128K ﹤0.01%
3,691
-5,818
-61% -$197K
LZB icon
2003
La-Z-Boy
LZB
$1.2B
$128K ﹤0.01%
3,179
+1,061
+50% +$38.4K
ZBRA icon
2004
Zebra Technologies
ZBRA
$17.5B
$127K ﹤0.01%
484
-169
-26% -$39.7K
NATL icon
2005
NCR Atleos
NATL
$3.41B
$127K ﹤0.01%
2,932
-2,115
-42% -$93.8K
HCSG icon
2006
Healthcare Services Group
HCSG
$1.44B
$127K ﹤0.01%
5,178
+1,426
+38% +$30.1K
PNR icon
2007
Pentair
PNR
$8.56B
$127K ﹤0.01%
1,658
-183
-10% -$14.5K
ROG icon
2008
Rogers Corp
ROG
$2.46B
$127K ﹤0.01%
776
+20
+3% +$2.75K
SBH icon
2009
Sally Beauty Holdings
SBH
$1.61B
$127K ﹤0.01%
8,954
-3,847
-30% -$51.9K
UVSP icon
2010
Univest Financial
UVSP
$1.16B
$126K ﹤0.01%
2,889
+1,417
+96% +$55.5K
HTO
2011
H2O America
HTO
$2.61B
$126K ﹤0.01%
2,077
-1,675
-45% -$97.1K
SMR icon
2012
NuScale Power
SMR
$3.46B
$126K ﹤0.01%
12,575
-1,410
-10% -$15.9K
SNDX icon
2013
Syndax Pharmaceuticals
SNDX
$1.63B
$126K ﹤0.01%
5,743
-8,689
-60% -$181K
SCL icon
2014
Stepan Co
SCL
$1.47B
$125K ﹤0.01%
2,251
+1,400
+165% +$72.8K
VSTS icon
2015
Vestis
VSTS
$1.8B
$125K ﹤0.01%
8,618
-1,341
-13% -$15K
NWBI icon
2016
Northwest Bancshares
NWBI
$2.24B
$125K ﹤0.01%
8,249
+304
+4% +$4.24K
NEO icon
2017
NeoGenomics
NEO
$2.48B
$125K ﹤0.01%
8,568
+3,775
+79% +$36.4K
LB
2018
LandBridge Co
LB
$2.41B
$125K ﹤0.01%
1,575
– –
HCI icon
2019
HCI Group
HCI
$2.18B
$125K ﹤0.01%
711
-108
-13% -$17K
RAPP
2020
Rapport Therapeutics
RAPP
$1.63B
$124K ﹤0.01%
2,976
-816
-22% -$30K
PSCU icon
2021
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$15.2M
$124K ﹤0.01%
1,876
-2,048
-52% -$132K
BEAM icon
2022
Beam Therapeutics
BEAM
$2.51B
$124K ﹤0.01%
3,610
-2,092
-37% -$63.2K
GRND icon
2023
Grindr
GRND
$2.74B
$123K ﹤0.01%
8,574
+5,962
+228% +$77.2K
CRSR icon
2024
Corsair Gaming
CRSR
$1.48B
$123K ﹤0.01%
12,727
+9,435
+287% +$73.1K
PLMR icon
2025
Palomar
PLMR
$3.26B
$123K ﹤0.01%
970
-1,676
-63% -$197K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.